507 results on '"Igaki H"'
Search Results
2. PO-1132 CSI or whole brain irradiation combined with HSCT for CNS recurrence of hematopoietic tumors.
3. PO-1855 Patients with cardiac implantable electronic devices: A Patterns of Care Survey for low-field MRgRT.
4. PO-2185 High-dose-rate brachytherapy in recurrent head and neck cancer after the previous radiotherapy
5. 1240P Activation status of CD8+ T and Treg cells in the tumor microenvironment potentially predicts the clinical efficacy of nivolumab in advanced esophageal squamous cell carcinoma
6. Edaravone, a known free radical scavenger, enhances X-ray-induced apoptosis at low concentrations
7. Variations in survival and perioperative complications between hospitals based on data from two phase III clinical trials for oesophageal cancer
8. The value of image coregistration during stereotactic radiosurgery
9. 607P Single institutional outcomes of radiotherapy and systemic therapy for melanoma brain metastases in Japan
10. Pattern of lymph node metastases of esophageal squamous cell carcinoma based on the anatomical lymphatic drainage system
11. Retrospective Multicenter Study of Stereotactic Irradiation for Metastatic Brain Tumors in Japan
12. The Treatment Results of Reduced Dose Radiotherapy For Gastric MALT Lymphoma
13. Reduced-Dose Whole Brain Radiation Therapy Combined With Stereotactic Irradiation For Solitary Or Oligo Brain Metastases Aiming At Minimizing Deterioration Of Neurocognitive Function Without Compromising Intracranial Tumor Control: Preliminary Results
14. Comparative Analysis of Esophageal Stenosis After Irradiation for T1N0M0 Esophageal Cancer Using Inverse Probability Weighting Between Prophylactic Irradiation After Endoscopic Treatment and Definitive Radiotherapy
15. Histological diversity in basaloid squamous cell carcinoma of the esophagus
16. Concurrent chemoradiation alone with curative intent for limited-disease small-cell esophageal cancer in nine Japanese patients
17. Radiation therapy combined with cis-diammine-glycolatoplatinum (nedaplatin) and 5-fluorouracil for Japanese stage II–IV esophageal cancer compared with cisplatin plus 5-fluorouracil regimen: a retrospective study
18. Predominant presence of Streptococcus anginosus in the saliva of alcoholics
19. Surgery for clinical T3 carcinomas of the upper thoracic oesophagus and the need for new strategies
20. SP-008: Clinical experiences and Dosimetry of MR guided X-ray Therapy (MRXT)
21. The Prognostic Factors for Radiation Pneumonitis ≥ Grade 2 in the Definitive Radiation Therapy in Non-Small Cell Lung Cancer Patients.
22. EP-1403 Retrospective evaluation of usefulness of MR-guided adaptive radiotherapy of gastric MALT lymphoma
23. EFFECT OF BIAXIAL STRESS STATES ON DYNAMIC FATIGUE OF SODA-LIME GLASS
24. Patterns of Pneumonitis after Chemoradiation Therapy and Immunotherapy for Stage III Non-Small Cell Lung Cancer
25. Analysis about Synchronization of Respiration-induced Motion at Duodenum, Stomach, and Lymph Node Regions for Primary tumor in Pancreatic Cancer Using 4-Dimensional Computed Tomography
26. EP-1766: Modelling of MR-guided radiotherapy system on Monte Carlo code GEANT4
27. Survival Time Prediction after Radiotherapy for Malignant Glioma Patients Based on Clinical and DVH Features Using Support Vector Machine
28. 430P Comparison of multimodality therapy in clinical stage IIIAN2 non-small cell lung cancer: consecutive analysis of surgery, radiotherapy, chemotherapy and their combination
29. Phase 2 Study of Neoadjuvant Chemoradiation Therapy With Cisplatin Plus 5-Fluorouracil and Elective Nodal Irradiation Followed by Surgery for Stage II/III Esophageal Squamous Cell Carcinoma
30. Supplementary Bladder Reference Point of High-Dose-Rate Intracavitary Brachytherapy for Cervical Cancer: Feedback 3-Dimension to 2-Dimension
31. EP-1115: Stereotactic radiosurgery for brain metastases: neuropathological report of three autopsy cases
32. Recurrence Pattern After Definitive Chemoradiation Therapy for Cervical Esophageal Cancer
33. Treatment Outcomes of Intensity Modulated Radiation Therapy for Clinical Stage I/II Hypopharyngeal Cancer
34. Radiation Dose to Ipsilateral Subventricular Zone as a Prognostic Factor in Malignant Glioma Patients
35. PD-0451: Plan comparison of volumetric modulated arc therapy with gamma knife radiosurgery for multiple brain metastases
36. Phase 2 Study of Neoadjuvant Chemoradiation Therapy With Cisplatin Plus 5-Fluorouracil and Elective Nodal Irradiation for Stage II/III Esophageal Squamous Cell Carcinoma
37. Patterns of Recurrence in Malignant Glioma Patients: Association With Neurogenic Niche and Radiation Therapy Dose
38. Impact of a Low Transmission Multileaf Collimator on the Parotid Grand Dose in Head and Neck Volumetric Modulated Arc Therapy Planning: A Dose-Volume Histogram Comparison Between 2-Step Adaptive and Simultaneously Integrated Boost Techniques
39. The Influence of Chemotherapy-Induced Leucopenia (Cil) During Preoperative Chemotherapy (Pre-Cx) on Survival in Esophageal Squamous Cell Carcinoma (Escc) from the Results of Jcog9907
40. Lung tumor motion reproducibility for five patients who received four-fraction VMAT stereotactic ablative body radiotherapy under constrained breathing conditions: a preliminary study
41. TH-E-BRF-05: Comparison of Survival-Time Prediction Models After Radiotherapy for High-Grade Glioma Patients Based On Clinical and DVH Features
42. The long-term outcomes of radiosurgery for intracranial hemangioblastomas
43. Longitudinal Assessments of Quality of Life and Late Toxicities Before and After Definitive Chemoradiation for Esophageal Cancer
44. Inhibitory Effect of Radiation-Induced Pulmonary Fibrosis by Spironolactone
45. Impact of flattening-filter-free techniques on delivery time for lung stereotactic volumetric modulated arc therapy and image quality of concurrent kilovoltage cone-beam computed tomography: a preliminary phantom study
46. EP-1009: Conventional and stereotactic radiotherapy for WHO grade II/III meningiomas.
47. AOSP3 DIAGNOSTIC AND SURGICAL OUTCOMES FOR PRIMARY MALIGNANT MELANOMA OF THE OESOPHAGUS FROM A SINGLE CENTRE
48. Feasibility Study of Neoadjuvant Chemoradiotherapy with Cisplatin Plus 5-Fluorouracil for Clinical Stage II/III Esophageal Squamous Cell Carcinoma
49. Soluble Interleukin 6 Receptor: A Serum Biomarker Predicting Preoperative Chemoradiotherapy Efficacy for Oesophageal Cancer
50. Final results of feasibility study of neoadjuvant chemotherapy with docetaxel, cisplatin, and fluorouracil (DCF) for clinical stage II/III esophageal squamous cell carcinoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.